login
login

Europe Daily Bulletin No. 12775

25 August 2021
Contents Publication in full By article 24 / 25
NEWS BRIEFS / Health
Valneva in discussions with EU as it expects vaccine candidate to be “more than 80%” effective against Covid-19

24/08/2021 (Agence Europe)The pharmaceutical company Valneva hopes that the phase III trial of its Covid-19 vaccine candidate (VLA2001), which is currently underway, will demonstrate “an efficacy rate of more than 80%”. These comments, which were made on 24 August by the company’s managing director, Franck Grimaud, were reported by AFP. The press agency notes that such efficiency would be lower than that of the vaccines from Pfizer/BioNTech and Moderna (which is 95%), but higher...

Contents

EXTERNAL ACTION
INSTITUTIONAL
SECTORAL POLICIES
ECONOMY - FINANCE - BUSINESS
EU RESPONSE TO COVID-19
SOCIAL AFFAIRS - EDUCATION
COUNCIL OF EUROPE
NEWS BRIEFS